LET 8 HFD-560 to McKenna & Cuneo Vol#: 7
82P-0316 Reclassify electroconvulsive therapy (ECT) SECTION 513(E)
C 817 The Honorable Peter DeFazio (CI) Vol#: 35
97S-0162 30-Day Structure Function Claim Notification Letters Dietary
C 1 Mr. Mrs. Gil Havinga Vol#: 35
C 2 Helen T. Mocedon Vol#: 35
LET 4588 Standard Process Vol#: 35
LET 4589 Standard Process Vol#: 35
LET 4590 Standard Process Vol#: 35
LET 4591 Standard Process Vol#: 35
LET 4592 Standard Process Vol#: 35
LET 4593 Supreme Health Products Corp. Vol#: 35
LET 4594 Supreme Health Products Corp. Vol#: 35
LET 4595 Rainbow Light Nutritional Systems, Inc. Vol#: 35
LET 4596 Murdock Madaus Schwabe Prof. Products Vol#: 35
LET 4597 Murdock Madaus Schwabe Prof. Products Vol#: 35
LET 4598 Herbal Science Inc. Vol#: 35
LET 4599 Herbal Science Inc. Vol#: 35
LET 4600 Bariatrix International, Inc. Vol#: 35
LET 4601 Bariatrix Intenational, Inc. Vol#: 35
LET 4602 Health From The Sun Vol#: 35
LET 4603 Nutritional Specialties, Inc. Vol#: 35
LET 4604 Nutritional Specialties, Inc. Vol#: 35
LET 4605 Nutritional Specialties, Inc. Vol#: 35
LET 4606 Nutritional Specialties, Inc. Vol#: 35
LET 4607 Nutritional Specialties, Inc. Vol#: 35
LET 4608 Nutritional Specialties, Inc. Vol#: 35
LET 4609 Nutritional Specialties, Inc. Vol#: 35
LET 4610 Nutritional Specialties, Inc. Vol#: 35
LET 4611 Nutritional Specialties, Inc. Vol#: 35
LET 4612 Nutritional Specialties, Inc. Vol#: 35
LET 4613 Nutritional Specialties, Inc. Vol#: 35
LET 4614 Nutritional Specialties, Inc. Vol#: 35
LET 4615 Nutritional Specialties, Inc. Vol#: 35
LET 4616 Nutritional Specialties, Inc. Vol#: 35
LET 4618 SHS International Vol#: 35
98N-0056 Sec 111(b)Pediatric Studies of list of Approved Drugs FDAMA
LET 13 HFD-1 to Merck & Co., Inc. Vol#: 3
99P-2077 Reg/Guide to Label Medical Devices contain'g Phthalate Plast
LET 3 HF-1 to Mount Sinai School of Medicine Vol#: 3
00D-0186 M4 Common Technical Document;InterNatl Confern on Harmonisat
00D-1223 Clinical Investigation of Medicinal Products in Pediatrics
C 1 Parke-Davis Pharmaceutical Research Vol#: 1
00F-0792 OLESTRA BE AMENDED REMOVING REQUIREMENT FOR LABEL STATEMENT
C 35 Center for Science in the Public Interes Vol#: 10
C 36 Evelyn G. Arnold Vol#: 10
C 37 Therese M. Popovits Vol#: 10
00N-1061 Resource Assessment of Programs and Services in Food Safety
C 1 Association of Food & Drug Officials Vol#: 1
00N-1198 Proposal to withdraw approval of 158 (ANDA)
WDL 2 SmithKline Beecham Vol#: 1
00N-1220 Future of the IntNatl Conf.on Harminization of Thechnical Re
00N-1257 International Drug Scheduling;Convention on Psychotropic
C 3 U.S. Department of Justice Vol#: 1
00P-0110 Add finasteride to priority section of "the List"
PDN 1 HFD-001 to Merck & Co., Inc Vol#: 1
00P-1211 Establish Mandatory Pre-Market Safety Testing for GE Foods
C 611 Charles & Katherine Ala Vol#: 20
C 612 Timothy Johnsen Vol#: 20
C 613 Susan J. Mather Vol#: 20
C 615 Daniel Karamanski Vol#: 20
C 616 John W. Lavelle Vol#: 20
C 621 Elizabeth R. Yesko Vol#: 20
C 624 Catherine Gordon Vol#: 20
C 626 Jessica L. Alexander Vol#: 20
C 627 Jennifer J. Roser Vol#: 20
C 628 Daniel C. Shively Vol#: 20
C 634 Francis G. Kostrub Vol#: 20
C 635 Domenica Ottero Vol#: 20
C 639 Teresa Jeffries Vol#: 20
C 650 James Washburne Vol#: 20
C 654 Neddy Astudillo Vol#: 20
C 655 Josephine Hannel Weber Vol#: 20
C 661 Patricia Bailey Vol#: 20
C 662 Joanna Wentraub Vol#: 20
C 665 Elden T. Boothe Vol#: 20
EMC 241 Kevin Shumway Vol#: 20
EMC 242 Pam Leland-Nelson Vol#: 20
EMC 243 Andrew Rock Vol#: 20
EMC 244 Julian Powers Vol#: 20
EMC 245 Anita Musser Vol#: 20
EMC 246 Jodi Peterson Vol#: 20
EMC 247 Katherine Jones Vol#: 20
EMC 248 Rainbeau Vol#: 20
EMC 249 Form Letters Count (437) Vol#: 21